ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,948.71
0.53%
US Tech 100
20,158.33
0.16%
Dow Jones
43,870.35
1.06%
Brent Oil
73.93
0.00%
Bitcoin
98,022.66
-0.50%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Immuron Limited (IMC) Quote

Immuron Limited

Immuron Limited (IMC)

Imc Exploration Group Plc
Ibero Mining Corp
0.075
0.00
( 0.00% )
Updated: 18:04:31
Delayed by 20 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.075
Bid
0.075
Ask
0.078
Volume
0.00
0.00 Day's Range 0.00
0.065 52 Week Range 0.17
Market Cap
17.085M
Previous Close
0.075
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
274,107
Shares Outstanding
227,798,346
Dividend Yield
-
PE Ratio
-2.30
Earnings Per Share (EPS)
-0.03
Revenue
8.31M
Net Profit
-6.94M

About Immuron Limited

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.immuron.com
Headquarters
Melbourne, Victoria, Aus
Founded
-
Immuron Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker IMC. The last closing price for Immuron was AUD0.08. Over the last year, Immuron shares have traded in a share price range of AUD 0.065 to AUD 0.17.

Immuron currently has 227,798,346 shares outstanding. The market capitalization of Immuron is AUD17.08 million. Immuron has a price to earnings ratio (PE ratio) of -2.30.

Ask ADVFN Intelligence (AI)

IMC Latest News

More News

Immuron Shares Hit 52-Week High After FDA Removes Clinical Hold

By Chris Wack Immuron Ltd. shares were up 45% to $2.71 after the company said that the U.S. Naval Medical Research Center has received approval from the U.S. Food and Drug Administration to...

May 08 2023
Dow Jones News

Immuron: FDA Removes Clinical Hold on New Campylobacter ETEC Therapeutic IND Application

By Chris Wack Immuron Ltd. said Monday that the U.S. Naval Medical Research Center has received approval from the U.S. Food and Drug Administration to proceed with the clinical evaluation of a new...

May 08 2023
Dow Jones News

Immuron Shares Jump 40%, Come Off Thursday's 52-Week Low

By Chris Wack Immuron Ltd. shares were up 40% to $2.26 after the company said Friday that it has received approval from the U.S. Food and Drug Administration to proceed with the clinical...

December 23 2022
Dow Jones News

Immuron Gets FDA Approval to Proceed With Travelan Evaluation

By Chris Wack Immuron Ltd. said Friday that it has received approval from the U.S. Food and Drug Administration to proceed with the clinical evaluation of Travelan. The company said the...

December 23 2022
Dow Jones News

Immuron in Travelan Clinical Trial Agreement with U.S.-based Pharmaron

By Chris Wack Immuron Ltd. said Tuesday that it has executed a master service agreement with U.S.-based Pharmaron CPC Inc. The biopharmaceutical company said its clinical trial agreement will...

October 04 2022
Dow Jones News

Immuron's New Drug Collaboration Put on Clinical Hold by FDA

By Connor Hart Immuron Ltd. on Tuesday said the U.S. Naval Medical Research Center received feedback from the U.S. Food and Drug Administration that its investigational new drug application...

July 26 2022
Dow Jones News

Immuron Request for More Funding for Travelan 'Eligible for Award'

By Chris Wack Immuron Ltd. said a new request for $4 million in funding has been considered to be "eligible for award" by the Medical Technology Enterprise Consortium, a U.S. Defense...

April 19 2022
Dow Jones News

Immuron Shares Rise 40% After Award for Travelan Study

By Chris Wack Immuron Ltd. shares were up 40% to $3.66 after the company said it was awarded 4.8 million Australian dollars ($3.4 million) in funding in a new research agreement with the U.S...

January 12 2022
Dow Jones News

Immuron in Research Agreement for Travelan With U.S. Defense Dept

By Chris Wack Immuron Ltd. said it was awarded 4.8 million Australian dollars ($3.4 million) in funding in a new research agreement with the U.S Department of Defense a study to clinically...

January 12 2022
Dow Jones News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.0750.080.0751197850.07863735DE
4-0.005-6.250.080.080.072780160.07618818DE
12-0.025-250.10.110.0722741070.08834057DE
26-0.015-16.66666666670.090.110.0722172800.09166863DE
52-0.005-6.250.080.170.0655521880.1167065DE
156-0.05-400.1250.170.0653408240.11034592DE
260-0.065-46.42857142860.140.950.055803600.2791028DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PCLOPancontinental Energy NL
AUD 0.01
(42.86%)
1.64M
IFGInFocus Group Holdings Ltd
AUD 0.052
(36.84%)
19.54M
T92OTerra Uranium Ltd
AUD 0.004
(33.33%)
20k
1TTThrive Tribe Technologies Ltd
AUD 0.004
(33.33%)
13.82k
RMLResolution Minerals Ltd
AUD 0.002
(33.33%)
54.04k
ADNOCAndromeda Metals Limited
AUD 0.001
(-50.00%)
10.75M
ARDOArgent Minerals Ltd
AUD 0.002
(-33.33%)
650k
SFGSeafarms Group Limited
AUD 0.001
(-33.33%)
10.31k
EUROEuropean Lithium Limited
AUD 0.004
(-33.33%)
250k
CZNCorazon Mining Ltd
AUD 0.003
(-25.00%)
10.7M
OVTOvanti Ltd
AUD 0.026
(0.00%)
36.63M
CDECodeifai Ltd
AUD 0.001
(0.00%)
35.27M
FFGFatfish Group Limited
AUD 0.016
(6.67%)
25.16M
IFGInFocus Group Holdings Ltd
AUD 0.052
(36.84%)
19.54M
SYASayona Mining Limited
AUD 0.035
(2.94%)
18.99M

Discussion

View Full Feed
The Night Stalker The Night Stalker 3 minutes ago
nice
KULR
SavetheOTC SavetheOTC 3 minutes ago
I wouldn't call it a nervous breakdown, but yeah, there's no way an actual breakthrough AI technolgy for mental health agreed to sell 100% for 10 million shares of NFTM.
NFTM
SavetheOTC SavetheOTC 3 minutes ago
I wouldn't call it a nervous breakdown, but yeah, there's no way an actual breakthrough AI technolgy for mental health agreed to sell 100% for 10 million shares of NFTM.
NFTM
jimr1717 jimr1717 4 minutes ago
Have the Korean Hedge Funds Covered their 6 trillion share short yet? Tia
IFUS
maxine523 maxine523 4 minutes ago
Well this is fun!
GeorgeTheStub GeorgeTheStub 5 minutes ago
$1.55 up now, have a good evening, GLTY tomorrow!
misterfishman misterfishman 5 minutes ago
We just need some news to stabilize this drifting down.
IGPK
Zardiw Zardiw 5 minutes ago
Damn.......Their real scariest weapon is threatening guys with harm to their family members.......that's how they control people.......

Z
jimr1717 jimr1717 5 minutes ago
Just a heads up, 🏆️ How did $102.000 in inventory disappear with no record? The last report filed shows that existing inventory fell from $120,000 of feed stock to $18,000 in a year ... even though there were only $20,000 of sales in the entire year. So, $102,000 of inventory disappeared wit
IFUS
hookrider hookrider 6 minutes ago
zab: Always!!!
ah86 ah86 6 minutes ago
Yes, you're wrong on some fronts. This is an open label trial. You can see failure from across the Atlantic. No company as is the case with this one, can have 'bad data' and put it in the fridge.
Patience is key here. Just over 3 bucks. You may walk away with some $$ if you sell now, though
MRKR
RIGATONI RIGATONI 6 minutes ago
100% cleaning house! ~Rig
Judah137 Judah137 6 minutes ago
Is it connected though? This guy seems to have the best investigational skills on the planet:

https://stocktwits.com/MDEUS33/message/585393569
NEOM
HyGro HyGro 6 minutes ago
Let's see how MHRA responds. FDA already reviewed NWBO's P3 and clearly did not encourage NWBO to apply for U.S. approval.

Once again show's AI's flaws as it has repeated errors in their statement.
NWBO
SkeBallLarry SkeBallLarry 7 minutes ago
Comcast Drops Bombshell on MSNBC – Greenlights $7 Billion Spinoff of Cable Channels >

https://pjnewsletter.com/msnbc-comcast-nbcuniversal-cable/
The Night Stalker The Night Stalker 7 minutes ago
nice
CAVR
12yearplan 12yearplan 7 minutes ago
[yt]S3WfSftHQnI[/yt]
noradio noradio 8 minutes ago
This company made 11 million in profit in 2023, am I reading the financials correctly?
CNRC
SavetheOTC SavetheOTC 8 minutes ago
Well, the flip side to that coin is all they've gained is shares, so if they can't create a demand for the stock, this will all be a huge waste of their time.
NFTM
facts_matter14 facts_matter14 8 minutes ago
I’m not hearing about “basket trades” anymore. Total silence. I wonder why………

POSRMX sucks!






.
SRMX
HyGro HyGro 9 minutes ago
PFS is not the ONLY acceptable endpoints for FDA acceptance -- they have list FIVE and PFS is one. Dr. Liau chose PFS as the primary endpoint for the SPORE UCLA. She also chose it for DCVax-L's P3 primary endpoint protocol too.
NWBO
SkeBallLarry SkeBallLarry 10 minutes ago
Comcast Drops Bombshell on MSNBC – Greenlights $7 Billion Spinoff of Cable Channels >

https://pjnewsletter.com/msnbc-comcast-nbcuniversal-cable/
LTListener LTListener 10 minutes ago
I am guessing the reference is to a larger funding package..
RSPI
SavetheOTC SavetheOTC 10 minutes ago
Do you have anything of value add or at least anything than bashing ecomike? What happened, you bought a stock based on his post that happened to be a lower? Investing in the OTC is a lot of losers with, hopefully, some big hits along the way.
NFTM

Your Recent History

ASX
IMC
Immuron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved